Characterization of the novel suramin analogue NF110 as a potent P2X3 receptor-selective antagonist

被引：0
|
作者：
Hausmann, R
Rettinger, J
Kassack, M
Lambrecht, G
Schmalzing, G
机构：
[1] Rhein Westfal TH Aachen, D-52074 Aachen, Germany
[2] Max Planck Inst Biophys, D-60439 Frankfurt, Germany
[3] Univ Bonn, Dept Pharmaceut Chem, D-53121 Bonn, Germany
[4] Univ Frankfurt, Dept Pharmacol, D-60439 Frankfurt, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2004年 / 369卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
111
引用
收藏
页码：R28 / R28
页数：1
相关论文
共 50 条
  • [1] The suramin analogue NF279 is a novel and potent antagonist selective for the P2X1 receptor
    Rettinger, J
    Schmalzing, G
    Damer, S
    Müller, G
    Nickel, P
    Lambrecht, G
    NEUROPHARMACOLOGY, 2000, 39 (11) : 2044 - 2053
  • [2] Structure -: Activity relationship studies of spinorphin as a potent and selective human P2X3 receptor antagonist
    Jung, Kwan-Young
    Moon, Hyoun Duk
    Lee, Ga Eun
    Lim, Hyun-Ho
    Park, Chul-Seung
    Kim, Yong-Chu
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (18) : 4543 - 4547
  • [3] Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist
    Brotherton-Pleiss, Christine E.
    Dillon, Michael P.
    Ford, Anthony P. D. W.
    Gever, Joel R.
    Carter, David S.
    Gleason, Shelley K.
    Lin, Clara J.
    Moore, Amy G.
    Thompson, Anthony W.
    Villa, Marzia
    Zhai, Yansheng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 1031 - 1036
  • [4] AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist
    Gever, Joel R.
    Soto, Rothschild
    Henningsen, Robert A.
    Martin, Renee S.
    Hackos, David H.
    Panicker, Sandip
    Rubas, Werner
    Oglesby, Ian B.
    Dillon, Michael P.
    Milla, Marcos E.
    Burnstock, Geoffrey
    Ford, Anthony P. D. W.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (06) : 1387 - 1398
  • [5] DT-0111: a novel P2X3 receptor antagonist
    Pelleg, Amir
    Sirtori, Elena
    Rolland, Jean-Francois
    Mahadevan, Anu
    PURINERGIC SIGNALLING, 2023, 19 (03) : 467 - 479
  • [6] DT-0111: a novel P2X3 receptor antagonist
    Amir Pelleg
    Elena Sirtori
    Jean-Francois Rolland
    Anu Mahadevan
    Purinergic Signalling, 2023, 19 : 467 - 479
  • [7] Mechanistic insights into the selective targeting of P2X3 receptor by camlipixant antagonist
    Thach, Trung
    Dhanabalan, Kanagavijayan
    Nandekar, Prajwal Prabhakarrao
    Stauffer, Seth
    Heisler, Iring
    Alvarado, Sarah
    Snyder, Jonathan
    Subramanian, Ramaswamy
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2025, 301 (01)
  • [8] NF279: a novel potent and selective antagonist of P2X receptor-mediated responses
    Damer, S
    Niebel, B
    Czeche, S
    Nickel, P
    Ardanuy, U
    Schmalzing, G
    Rettinger, J
    Mutschler, E
    Lambrecht, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 350 (01) : R5 - R6
  • [9] P2X3 receptor antagonist in chronic cough
    Turner, Richard D.
    Rajakulasingam, Raj K.
    Bhowmik, Angshu
    Bothamley, Graham H.
    LANCET, 2015, 386 (9990): : 244 - 244
  • [10] Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist
    Rettinger, J
    Braun, K
    Hochmann, H
    Kassack, MU
    Ullmann, H
    Nickel, P
    Schmalzing, G
    Lambrecht, G
    NEUROPHARMACOLOGY, 2005, 48 (03) : 461 - 468
12345